Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
RegeneRx Biopharmaceuticals Inc. (RGRX) Days Sales in Receivables data is not available for the most recently reported fiscal quarter, ending 2023-03-31.
| Income Statement Financials | |
$0.02M |
|
$-0.39M |
|
-- |
|
$0.02M |
|
$0.32M |
|
$-0.30M |
|
$-0.08M |
|
$-0.39M |
|
$-0.39M |
|
$-0.39M |
|
$-0.39M |
|
$-0.39M |
|
$-0.39M |
|
$-0.30M |
|
$-0.30M |
|
1.44M |
|
1.44M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.12M |
|
-- |
|
$0.06M |
|
$0.19M |
|
$1.80M |
|
$0.26M |
|
$2.13M |
|
$3.93M |
|
$-3.74M |
|
$-3.74M |
|
$-3.74M |
|
1.44M |
|
| Cash Flow Statement Financials | |
$-0.19M |
|
-- |
|
-- |
|
$0.29M |
|
$0.10M |
|
$-0.19M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.07 |
|
-- |
|
-- |
|
-0.08 |
|
-0.38 |
|
100.00% |
|
-1588.91% |
|
-1588.91% |
|
-- |
|
-2007.30% |
|
-2007.30% |
|
$-0.19M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
|
Days Sales in Receivables |
-- |
10.29% |
|
10.29% |
|
-206.20% |
|
11.06% |
|
$-2.61 |
|
$-0.13 |
|
$-0.13 |
|